Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects



Rating:

Share or cite this content

Citations should be made in the following way:
K. Walicka-Serzysko (Warsaw, Poland), M. Postek (Warsaw, Poland), J. Milczewska (Warsaw, Poland), N. Jeneralska (Dziekanow Lesny, Poland), A. Cichocka (Dziekanow Lesny, Poland), E. Siedlecka (Dziekanow Lesny, Poland), L. Morin (Montpellier, France), D. Sands (Warsaw, Poland). Late Breaking Abstract - Effects of a new airway clearance technology in children with cystic fibrosis - A homecare randomized controlled trial. 3379

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Telerehabilitation compared to centre-based pulmonary rehabilitation: a randomised controlled equivalence trial. Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Effect on asthma control using a novel digital self-management system: a physician blinded randomised controlled cross-over pilot trial Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Effects of a home programme of airway clearance techniques on adventitious respiratory sounds in patients with bronchiectasis: a randomised controlled trial Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Late Breaking Abstract - Effects of long-term Tobramycin Inhalation Solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. The BATTLE Randomized Controlled Trial Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT) Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Hypertonic saline nebulization combined with oscillatory positive expiratory pressure accelerate sputum clearance in cystic fibrosis: A randomised crossover trial Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016 Late Breaking Abstract - Benefits of a low-frequency airway clearance technology in non-CF patients with bronchiectasis Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction Year: 2018 Late Breaking Abstract - Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children: a randomized controlled trial Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Exercise training is beneficial in patients with non-cystic fibrosis bronchiectasis – A multi-centre, randomised controlled trial Source: Annual Congress 2012 - Exercise and physical activity: towards evidence-based benefits in different populations Year: 2012 Late Breaking Abstract - Inhaled indacaterol does not affect lung function or symptoms in lymphangioleiomyomatosis: a double blind placebo controlled cross-over trial Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis- A randomised controlled trial Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - Randomised trial of ambulatory management of primary spontaneous pneumothorax Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis Year: 2020